Yayınlar & Eserler

Yayın Ağı
Makaleler 84
Tümü (84)
SCI-E, SSCI, AHCI (80)
SCI-E, SSCI, AHCI, ESCI (82)
ESCI (2)
Scopus (81)
TRDizin (3)

1. Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case–control study

Bukun H. O., UYGUNOĞLU U., Senturk E. F., Duru G., KIZILKILIÇ O., ESATOĞLU S. N., et al.
Rheumatology International , cilt.46, sa.3, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

2. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.
Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

3. Long-term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra

Toker Dincer Z., Raimoglou D., YILMAZ B. E., Dag A., MELİKOĞLU M., UĞURLU S.
Internal Medicine Journal , 2026 (SCI-Expanded, Scopus) identifier identifier

4. Diagnostic value of vein wall thickness measurement for patients with suspected Behcet syndrome

Bayraktar R. A., KAYADİBİ Y., Kahveci A., ESATOĞLU S. N., ADALETLİ İ., ÖZGÜLER Y., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.4939-4941, 2025 (SCI-Expanded, Scopus) identifier

5. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review Anakinra bei idiopathischer rezidivierender Perikarditis: umfangreiche Fallserie und Literaturübersicht

Toker Dincer Z., Karup S., YILMAZ B. E., Corbali O., Azman F. N., MELİKOĞLU M., et al.
Zeitschrift fur Rheumatologie , cilt.83, sa.7, ss.587-596, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

7. Long-Term Echocardiographic Findings in Idiopathic Recurrent Pericarditis Patients Treated with Anakinra

TOKER DİNÇER Z., Raimoglu D., YILMAZ ALARÇİN E., DAĞ A., Karup S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.2279-2281, 2024 (SCI-Expanded, Scopus) identifier

8. Erythematous annular atrophic patchy lesions in the bilateral axillae

UZUNÇAKMAK T. K., Bayindir E., ÖNENERK MEN A. M., MELİKOĞLU M.
CLINICAL AND EXPERIMENTAL DERMATOLOGY , sa.12, ss.1752-1754, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier

9. A Proposal of a New Tool for the Assessment of Damage in Behçet Syndrome Uveitis: Cerrahpasa Ocular Damage Grading System

Ozyazgan Y., UÇAR D., BATU OTO B., ESATOĞLU S. N., ÖZGÜLER Y., HATEMİ G., et al.
Ocular Immunology and Inflammation , cilt.32, sa.10, ss.2332-2338, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

10. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.
Rheumatology International , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

11. Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behcet Syndrome

ÖZTÜRK M., ESATOĞLU S. N., HATEMİ A. İ., ÇELİK A. F., KARGIN O. A., ÖZ A., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3067-3068, 2023 (SCI-Expanded, Scopus) identifier

12. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus) identifier

13. Sistemik lupus eritematozusda plazma değişim tedavisi: Tek merkez retrospektif kohort çalışması

Özgüler Y., Ak T., Esatoğlu S. N., Elverdi T., Eşkazan A. E., Uğurlu S., et al.
Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.89-94, 2023 (TRDizin)

14. Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis

Özince R. B., Ak T., Erzin Y. Z., Melikoğlu M., Seyahi E.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.0, sa.0, 2023 (SCI-Expanded, Scopus)

15. Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis

Ak T., Özince R. B., Erzin Y. Z., Melikoğlu M., Seyahi E.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.00, sa.00, 2023 (SCI-Expanded, Scopus)

16. Post-COVID-19 vaccination inflammatory syndrome: A case report.

Durucan I., Guner S., Kilickiran Avci B., Unverengil G., MELİKOĞLU M., UĞURLU S.
Modern rheumatology case reports , cilt.7, sa.1, ss.280-282, 2023 (ESCI) Creative Commons License identifier identifier identifier

17. ANCA ile ilişkili vaskülitte plazma değişim tedavisi: Tek merkez retrospektif kohort çalışması

Özgüler Y., Ak T., Esatoğlu S. N., Elverdi T., Eşkazan A. E., Uğurlu S., et al.
Ulusal Romatoloji Dergisi , cilt.14, sa.3, ss.131-136, 2022 (Scopus, TRDizin) identifier identifier

18. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.
RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. Venous Halo Sign Detected with Superb Microvascular Imaging in Behcet Syndrome

KAYADİBİ Y., Ozguler Y., MELİKOĞLU M., ESATOĞLU S. N., ÜSTÜNDAĞ A., KİMYON U., et al.
ARTHRITIS & RHEUMATOLOGY , ss.2458-2459, 2022 (SCI-Expanded, Scopus) identifier

20. The clinical, functional, and radiological features of hand osteoarthritis: TLAR-osteoarthritis multi-center cohort study

DURUÖZ M. T., Gursoy D. E., Tuncer T., ALTAN İNCEOĞLU L., Ayhan F., Bal A., et al.
ARCHIVES OF RHEUMATOLOGY , cilt.37, sa.3, ss.375-382, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

21. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus) identifier

22. Impact of apremilast on quality of life in Behcet's syndrome: analysis of the phase 3 RELIEF study

HATEMİ G., Mahr A., Takeno M., Kim D., MELİKOĞLU M., Cheng S., et al.
RMD OPEN , cilt.8, sa.2, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

23. Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behcet's syndrome?

Taflan S. S., ESATOĞLU S. N., ÖZGÜLER Y., YURTTAŞ B., MELİKOĞLU M., HATEMİ G.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.448-450, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

24. RARE CARDIAC PRESENTATION OF WEGENER GRANULOMATOSIS AS STERILE VEGETATION

Akman Z., Koroglu A. E., Yurttas B., Melikoglu M., Avci B. K., Ongen Z.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.79, sa.9, ss.3231, 2022 (SCI-Expanded, Scopus) identifier

25. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

26. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.
Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

27. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome: Reply

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.
Rheumatology (United Kingdom) , cilt.59, sa.4, ss.914-915, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

28. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.
Rheumatology (United Kingdom) , cilt.59, sa.4, ss.799-806, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

29. Trial of Apremilast for Oral Ulcers in Behcet's Syndrome

Hatemi G., Mahr A., Ishigatsubo Y., Song Y., Takeno M., Kim D., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.381, sa.20, ss.1918-1928, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

30. Outcome of invasive procedures for venous thrombosis in Behçet's syndrome: case series and systematic literature review.

Dincses E., Esatoglu S. N., Fresko İ., MELİKOĞLU M., Seyahi E.
Clinical and experimental rheumatology , sa.6, ss.125-131, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

31. Disease Course of Behcet's Syndrome Patients Not Fulfilling International Study Group Criteria at Presentation

Esatoglu S. N., Bilgin S., Sulu C., Hamuryudan V., Kutlubay Z., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

32. Secukinumab induced Behcet's syndrome: a report of two cases

DİNÇSES NAS E., YURTTAŞ B., ESATOĞLU S. N., MELİKOĞLU M., HAMURYUDAN V., SEYAHİ E.
OXFORD MEDICAL CASE REPORTS , sa.5, ss.239-241, 2019 (ESCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

33. Biosimilar infliximab for Behcet's syndrome: a case series

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.111-115, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

34. Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study

Hatemi G., Mahr A., Ishigatsubo Y., Song Y. W., Melikoglu M., Cheng S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

35. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

36. Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome in a Phase III Study: A Prespecified Analysis By Baseline Patient Demographics and Disease Characteristics

Hatemi G., Mahr A., Takeno M., Kim D., Melikoglu M., Cheng S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus) identifier

37. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

38. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci Ş., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.12, ss.1719-1725, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

39. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

40. Pulmonary artery involvement in Behçet's syndrome: Effects of anti-Tnf treatment

Hamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., et al.
Seminars in Arthritis and Rheumatism , cilt.45, sa.3, ss.369-373, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

41. Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome

Seyahi E., Cakmak O. S., Tutar B., Arslan C., Dikici A. S., Sut N., et al.
Medicine (United States) , cilt.94, sa.44, 2015 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

42. Can We Differentiate Takayasu's Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?

UĞURLU S., KESKİN F. E., CETINKAYA F., MELİKOĞLU M., HAMURYUDAN V., FRESKO İ., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

43. Restarting biologic agents in rheumatology patients who developed tuberculosis under TNF alpha-inhibitor treatment

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.
EUROPEAN RESPIRATORY JOURNAL , cilt.46, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

44. Apremilast for Behçet's syndrome - A phase 2, placebo-controlled study

Hatemi G., Melikoglu M., Tunc R., Korkmaz C., Ozturk B. T., Mat C., et al.
New England Journal of Medicine , cilt.372, sa.16, ss.1510-1518, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

45. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behcet's syndrome followed up at a single, dedicated center

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.44, sa.5, ss.602-609, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

46. Effect of Apremilast on Quality of Life and Physical Function in Patients with Behcet's Syndrome.

Hatemi G., Melikoglu M., Tunc R., Korkmaz C., ÖZTÜRK B. T., Mat C., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) identifier

47. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) identifier

48. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) identifier

49. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) identifier

50. Vascular involvement in behceţ's syndrome: Aretrospective analysis of associations and the time course

Tascilar K., Melikoglu M., Ugurlu S., Sut N., Caglar E., Yazici H.
Rheumatology (United Kingdom) , cilt.53, sa.11, ss.2018-2021, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

51. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome

Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus) identifier

52. Calciphylaxis: A Report of Six Cases and Review of Literature

Yalin A. S., Altiparmak M. R., Trabulus S., Yalin S. F., Yalin G. Y., Melikoglu M.
RENAL FAILURE , cilt.35, sa.1, ss.163-169, 2013 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

53. Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists

Hatemi G., Melikoglu M., Ozbakir F., Tascilar K., Yazici H.
Arthritis Research and Therapy , cilt.14, sa.3, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

54. Pulmonary Artery Involvement and Associated Lung Disease in Behcet Disease A Series of 47 Patients

Seyahi E., Melikoglu M., Akman C., Hamuryudan V., Ozer H., Hatemi G., et al.
MEDICINE , cilt.91, sa.1, ss.35-48, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

55. The estimated pulmonary artery pressure can be elevated in Behcet's syndrome

Seyahi E., Baskurt M., Melikoglu M., Akman C., Olgun D., Simsek E., et al.
RESPIRATORY MEDICINE , cilt.105, sa.11, ss.1739-1747, 2011 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

56. Major vessel involvement in Behcet's disease: an update

Calamia K. T., Schirmer M., Melikoglu M.
CURRENT OPINION IN RHEUMATOLOGY , cilt.23, sa.1, ss.24-31, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

57. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus) identifier

58. The Mucocutaneous Manifestations and Pathergy Reaction in Behcet's Disease

Mat M. C., Bang D., Melikoglu M.
BEHCET'S SYNDROME , ss.53-72, 2010 (SCI-Expanded) identifier

59. Vascular Disease in Behcet's Syndrome

Hamuryudan V., Melikoglu M.
BEHCET'S SYNDROME , ss.115-133, 2010 (SCI-Expanded) identifier identifier

60. The unique features of vasculitis in Behcet's syndrome

Melikoglu M., Kural-Seyahi E., Tascilar K., Yazici H.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY , cilt.35, ss.40-46, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

61. Frequency of pathergy phenomenon and other features of Behçet`s syndrome among patients with inflammatory bowel disease

Hatemi A. İ., Çelik A. F., Hatemi G., Melikoğlu M., Arzuhal N., Mat C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.50, sa.4, ss.91-95, 2008 (SCI-Expanded, Scopus)

62. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

63. PPD REACTION IS NOT AUGMENTED IN BEHCET'S SYNDROME PATIENTS

Hatemi G., Melikoglu M., Sut N., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus) identifier

64. Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease

Hatemi I., Hatemi G., Çelik A. B., Melikoglu M., Arzuhal N., Mat C., et al.
Clinical and Experimental Rheumatology , cilt.26, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

65. Purified protein derivative reaction is not augmented in Behçet's syndrome patients

Hatemi G., Melikoglu M., Sut N., Yazici H.
Rheumatology , cilt.47, sa.5, ss.733-734, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

66. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome

Seyahi E., Hamuryudan V., Hatemi G., Melikoglu M.
RHEUMATOLOGY , cilt.46, sa.7, ss.1213-1214, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

67. Infliximab does not suppress the tuberculin skin test (purified protein derivative)

Hatemi G., Melikoglu M., Fresko I., Masatlioglu S., Tascilar K., Yazici H.
JOURNAL OF RHEUMATOLOGY , cilt.34, sa.3, ss.474-480, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

68. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers

Melikoglu M., Uysal S., Krueger J. G., Kaplan G., Gogus F., Yazici H., et al.
JOURNAL OF IMMUNOLOGY , cilt.177, sa.9, ss.6415-6421, 2006 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

69. Behcet's Syndrome

Mat M. C., Demirkesen C., Melikoglu M., Yazici H.
SKIN IN SYSTEMIC AUTOIMMUNE DISEASES , cilt.5, ss.185-206, 2006 (SCI-Expanded) identifier identifier identifier

70. Fibrinolytic activity and d-dimer levels in Behcet's syndrome

Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

71. Do MEFV mutations play a role in the development of Behçet's disease related amyloidosis? [2]

Akpolat T., Yilmaz E., Ozdogan H., Melikoglu M., Altiok E., Ozen S.
Clinical and Experimental Rheumatology , cilt.23, sa.2, ss.273-274, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

72. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

73. Major vessel involvement in Behçet disease

Calamia K., Schirmer M., Melikoglu M.
Current Opinion in Rheumatology , cilt.17, sa.1, ss.1-8, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

74. Anti-endothelial cell antibodies in Behçet's disease

Dinc A., Takafuta T., Jiang D., Melikoglu M., Saruhan-Direskeneli G., Shapiro S.
Clinical and Experimental Rheumatology , cilt.21, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

75. Neutrophilic pleocytosis in cerebrospinal fluid: Adult-onset Still's disease

Tabak F., Tanverdi M., Ozaras R., Mert A., Tartan Z., Ozturk R., et al.
INTERNAL MEDICINE , cilt.42, sa.10, ss.1039-1041, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

76. Target organ associations in Turkish patients with Behçet's disease: A cross sectional study by exploratory factor analysis

Tunc R., Keyman E., Melikoglu M., Fresko İ., Yazici H.
Journal of Rheumatology , cilt.29, sa.11, ss.2393-2396, 2002 (SCI-Expanded, Scopus) identifier identifier identifier

77. Nailfold capillary abnormalities in patients with familial Mediterranean fever

Dinc A., Melikoglu M., Korkmaz C., Fresko İ., Ozdogan H., Yazici H.
Clinical and Experimental Rheumatology , cilt.19, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

78. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome

Tunc R., Uluhan A., Melikoglu M., Ozyazgan Y., Ozdogan H. A., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.19, sa.5, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

79. A reappraisal of amyloidosis in Behçet's syndrome.

Melikoglu M., Altiparmak M. R., Fresko I., Tunc R., Yurdakul S., Hamuryudan V., et al.
Rheumatology (Oxford, England) , cilt.40, sa.2, ss.212-5, 2001 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

80. Intestinal permeability in Behcet's syndrome

Fresko İ., Hamuryudan V., Demir M., Hizli N., Sayman H. B., Melikoglu M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.1, ss.65-66, 2001 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

81. A survey of phenotype II in familial Mediterranean fever

Melikoglu M., Ozdogan H. A., Korkmaz C., Kasapcopur O., Arisoy N., Akkus S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.59, sa.11, ss.910-913, 2000 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

82. Behcet's disease in the Middle East

Saylan T., Mat C., Fresko İ., Melikoglu M.
Clinics in Dermatology , cilt.17, sa.2, ss.209-223, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

83. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.
RHEUMADERM , cilt.455, ss.135-140, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

84. Calciphylaxis: A condition mimicking necrotizing vasculitis

Melikoglu M., Apaydin S., Hamuryudan V., Yurdakul S., Uygun N., Aki H., et al.
CLINICAL RHEUMATOLOGY , cilt.15, sa.5, ss.498-500, 1996 (SCI-Expanded, Scopus) identifier identifier identifier
Metrikler

Yayın

126

Yayın (WoS)

94

Yayın (Scopus)

82

Atıf (WoS)

2498

H-İndeks (WoS)

27

Atıf (Scopus)

2829

H-İndeks (Scopus)

27

Atıf (Scholar)

11

H-İndeks (Scholar)

2

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

1

Açık Erişim

17
BM Sürdürülebilir Kalkınma Amaçları